01/10/2025
3:50 PM | Panbela Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/19/2024
5:40 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:00 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:01 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:02 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:03 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:04 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:05 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
5:00 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
|
11/15/2024
5:15 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:03 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:06 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:09 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
6:40 PM | Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13D | |
10/29/2024
6:38 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:27 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
4:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:26 PM | Horvath Susan (Reporting)
Panbela Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:34 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:25 PM | Panbela Therapeutics (Filer)
| Form S-1/A | |
08/13/2024
7:39 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:40 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:42 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:43 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:45 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:46 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:47 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
4:30 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
07/30/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:46 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
A simple pattern that works in any market (Ad) Right when most traders were getting bearish, The All-Weather Pattern signaled something different.
Following this setup could've turned every $1,000 into $1,770 in just 48 hours.
But here's what really gets me excited...
You don't need to be glued to your screen all day, no complex formulas, no guessing.
Just wait for a stock to close below The All-Weather Pattern, then check if it opens higher the next morning.
That's it.
While of course I cannot promise future returns or against losses…
I've put together a complete breakdown of how this works, including the new stock that’s tending towards The All-Weather Pattern this week. If you’re interested, the complete details are all here. |
05/29/2024
6:00 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:21 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:22 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:24 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:27 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:29 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
3:35 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
8:09 AM | Nasdaq Stock Market LLC (Filed by)
Panbela Therapeutics (Subject)
| Form 25-NSE | |
04/22/2024
7:02 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:31 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/17/2024
7:36 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
3:17 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
03/29/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form POS AM | |
03/29/2024
4:24 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/26/2024
3:15 PM | Panbela Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:12 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:01 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:05 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:10 PM | Lind Global Fund II LP (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
4:24 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
6:15 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:28 PM | Panbela Therapeutics (Filer)
| Form 424B4 | |
01/29/2024
5:21 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
01/25/2024
11:22 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/25/2024
7:54 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/22/2024
5:08 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
